SCHEMBL7507947

SCHEMBL7507947

Cc1cc(Cl)ccc1-c1oc(Cc2ccccc2)nc1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CA1 P00915 7/20 0.43
▸ CA2 P00918 7/20 0.43
▸ CA12 O43570 4/20 0.43
▸ CA9 Q16790 4/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ RXRA P19793 4/20 0.42
▸ RXRB P28702 4/20 0.42
▸ PTGS1 P23219 8/20 0.41
▸ PTGS2 P35354 8/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ RXRG P48443 2/20 0.39
▸ MT-CO2 P00403 1/20 0.39
▸ CA3 P07451 1/20 0.39
▸ ADRB2 P07550 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7506418 0.92 MAPT (0.44) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7503849 0.91 PTGS2 (0.47) LMNAMAPTALDH1A1RXRARXRB
SCHEMBL7509654 0.90 RXRA (0.46) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7499302 0.90 CA1 (0.51) LMNAMAPTCA1CA2CA12
SCHEMBL7505567 0.88 PTGS2 (0.50) LMNACA1CA2CA12CA9
SCHEMBL7503365 0.88 RXRA (0.56) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7504402 0.88 RXRA (0.53) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7499023 0.88 CA2 (0.43) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7507875 0.86 CA1 (0.43) LMNAMAPTALDH1A1CA1CA2
SCHEMBL7504153 0.85 RXRA (0.53) LMNAMAPTALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback